Comparison

EBV LMP2 131-139 (HLA-A*24:02) European Partner

€115.00
Excl. VAT
Item no. EP05807_5
Manufacturer peptides & elephants
Amount 5 mg
Category
Type Peptides
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias PYLFWLAAI Latent membrane protein HLA-A*24:02 Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Available
Description
Single peptide (PYLFWLAAI) for stimulation of human EBV LMP2(131-139)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*24:02 allele.
Keywords
PYLFWLAAI Latent membrane protein HLA-A*24:02 Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Sequence
PYLFWLAAI
N-Terminus
H
C-Terminus
OH
Purity
0, 95
Counter-Ion
TFA
Protein
Latent membrane protein
Gene
LMP2
Allele
HLA-A*24:02
Application
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication
Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma
Storage
Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
Listprice: €115.00
Price: €115.00
available

Delivery expected until 9/18/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close